EP. 13: Case 2 Discussion and Considerations for Second-Line Treatment Selection
The panelists discuss Dr Cluzeau’s presented case, emphasizing the importance of pathology reporting, and expand upon approaches to second-line treatment selection for patients with MDS-RS.